| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 10/06/2010 | CN101057942B External applied medicine ointment for treating diabetes foot and its preparing method |
| 10/06/2010 | CN101049494B Composition of medicine for treating alopecia and preparation method |
| 10/05/2010 | US7807787 NELL-1 (Nel-like molecule-1) polypeptide for use in induction and treatment of bone formation and disorders |
| 10/05/2010 | US7807643 Compositions containing leptin |
| 10/05/2010 | US7807463 Pretreatment of animal with antibodies to sensitize animal; controlling dosage |
| 10/05/2010 | US7807461 Multipotent stem cells derived from human adipose tissue and cellular therapeutic agents comprising the same |
| 10/05/2010 | US7807458 Nutrient broth comprising multipotent cells for use in propagation of mesodermal, neuroectodermal, and endodermal cells; tissue engineering |
| 10/05/2010 | US7807457 Recombinant viral and non-viral vectors containing the human urokinase plasminogen activator gene and its utilization in the treatment of various types of hepatic, renal, pulmonary, pancreatic and cardiac fibrosis and hypertrophic scars |
| 10/05/2010 | US7807440 Ability to colonize the human vagina; bacterial vaginosis, viral vaginosis, yeast vaginitis, infections in the vagina, urinary tract infection |
| 10/05/2010 | US7807430 Polypeptide of 250-419 contiguous amino acids of SEQ ID NO:1, where tyrosine 216 is phosphorylated and the polypeptide will crystallize; biological activity consisting of binding a GSK3 inhibitor and kinase activity; antidiabetic agents; Alzeimer's disease; antiinflammation agents; biological screening |
| 10/05/2010 | US7807384 Drug screening; identifying a candidate agent that inhibits the binding of low density lipoprotein binding protein-2 (LBP-2) to an LBP-2 binding molecule |
| 10/05/2010 | US7807185 applying to skin or mucous membrane of a mammal a composition comprising an extracellular product of a Pseudomonas lindbergii strain, an extracellular product of a Bacillus coagulans strain, and an anti-fungal agent selected from Amphotericin B, Carbol-Fuchsin, Ciclopirox, for example |
| 10/05/2010 | US7807179 Reoviridae virus is conjugated to a hydroxylated hydrocarbon or a polycationic polymer to reduce the clearance and immunogenicity; antiproliferative disorders |
| 10/05/2010 | US7807170 Modulating an immune response in a subject by administering an effective amount of a lymphocyte differentiation factor; antiinflammatory agents |
| 10/05/2010 | US7807151 identifying a mammalian subject having an infection with said pathogenic Clostridium bacterium resistant to antibiotic, orally administering a therapeutically-effective concentration of Bacillus coagulans bacteria |
| 10/05/2010 | US7807150 Injectable composition containing crosslinkable material and cells for forming animal tissue |
| 10/05/2010 | US7807149 treatment of a bacterial infection characterized by biofilm formation; for Pseudomonas aeruginosa infections such as those in canine ears |
| 10/05/2010 | US7807148 Organotypically cultured skin tissue comprising NIKS cells that express exogenous HIF-1a |
| 10/05/2010 | US7807147 Tumor therapy with high affinity laminin receptor-targeted vectors |
| 10/05/2010 | US7806937 Tissue engineered female reproductive organs |
| 10/05/2010 | CA2444809C A non-lethal method for extracting crude hemocyanin from gastropod molluscs |
| 10/05/2010 | CA2428662C Small acid-soluble spore protein and uses thereof |
| 09/30/2010 | WO2010111631A1 Tumor suppression using human placenta-derived intermediate natural killer cells and immunomodulatory compounds |
| 09/30/2010 | WO2010111414A1 Factor viii variants and methods of use |
| 09/30/2010 | WO2010110374A1 Agent for enhancing hypoglycemic activity |
| 09/30/2010 | WO2010110045A1 Process for producing lactic acid bacterium having enhanced immunomodulating activity |
| 09/30/2010 | WO2010108950A1 Use of a probiotic to regulate body weight |
| 09/30/2010 | WO2010108865A1 Use of probiotics to ameliorate diet-induced insulin resistance |
| 09/30/2010 | WO2010108665A1 Promotion of neuronal integration in neural stem cell grafts |
| 09/30/2010 | WO2010108503A1 Promotion of neuronal integration in neural stem cell grafts |
| 09/30/2010 | WO2010108262A1 TISSUE KALLIKREIN FOR THE TREATMENT OF PANCREATIC β-CELL DYSFUNCTION |
| 09/30/2010 | WO2010108237A1 Method of tissue repair |
| 09/30/2010 | WO2010081126A3 Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin |
| 09/30/2010 | WO2010076400A8 Use of an anti-cd20 antibody for treating primary intraocular lymphoma |
| 09/30/2010 | WO2010056075A3 Composition comprising mesenchymal stem cells or culture solution of mesenchymal stem cells for the prevention or treatment of neural diseases |
| 09/30/2010 | WO2010017216A8 Mesenchymal stromal cell populations and methods of isolating and using same |
| 09/30/2010 | US20100249924 Bioerodible matrix for tissue involvement |
| 09/30/2010 | US20100249376 NELL Peptide Expression Systems and Bone Formation Activity of NELL Peptide |
| 09/30/2010 | US20100248205 Reovirus Clearance of Ras-Mediated Neoplastic Cells from Mixed Cellular Compositions |
| 09/30/2010 | US20100247672 Polyurethane/bone compositions and methods |
| 09/30/2010 | US20100247671 Method and composition for alleviating or preventing ischemic tissue damage |
| 09/30/2010 | US20100247670 Red Grape Dry Composition and Health Tea |
| 09/30/2010 | US20100247622 Treatment regime for proliferative disorders |
| 09/30/2010 | US20100247605 Three Dimensional Cell Protector/Pore Architecture Formation for Bone and Tissue Constructs |
| 09/30/2010 | US20100247604 Method of treatment of connective tissues and organs and uses of said tissues and organs |
| 09/30/2010 | US20100247601 Repair and treatment of bone defect using cells induced by agent produced by chondrocytes capable of hypertrophication and scaffold |
| 09/30/2010 | US20100247595 Porous structures and methods of use |
| 09/30/2010 | US20100247579 Therapeutic agent for cancer |
| 09/30/2010 | US20100247559 West nile virus vaccine, and method for production thereof |
| 09/30/2010 | US20100247553 Goodpasture Antigen Binding Protein |
| 09/30/2010 | US20100247535 Chemically Programmable Immunity |
| 09/30/2010 | US20100247518 Modified proteins, designer toxins, and methods of making thereof |
| 09/30/2010 | US20100247502 Tumor/b-cell hybrid cells and uses thereof |
| 09/30/2010 | US20100247501 Foodstuff comprising an extract of a plant of the genus salacia and flavonoid |
| 09/30/2010 | US20100247500 Agent and method for improving survivability of lactic acid bacterium, and food composition |
| 09/30/2010 | US20100247499 hUTC AS THERAPY FOR ALZHEIMER'S DISEASE |
| 09/30/2010 | US20100247497 Vector particles for targetng cd34+ cells |
| 09/30/2010 | US20100247496 Neuronal viability factor and use thereof |
| 09/30/2010 | US20100247495 Treatment of Muscular Dystrophy |
| 09/30/2010 | US20100247494 Compositions of Mesenchymal Stem Cells to Regenerate Bone |
| 09/30/2010 | US20100247493 Method for Identifying and Selecting Cardiomyocytes |
| 09/30/2010 | US20100247492 Methods for the detection of circulating tumor cells |
| 09/30/2010 | US20100247491 Potentiation of Stem Cell Homing and Treatment of Organ Dysfunction or Organ Failure |
| 09/30/2010 | US20100247490 SIMIAN E ADENOVIRUSES SAdV-39, -25.2, -26, -30, -37, AND -38 |
| 09/30/2010 | US20100247489 Use of a composition made of mineral nutrients and optionally acetogenic and/or butyrogenic bacteria in order to avoid or reduce the formation of gas in the large intestine of a mammal and the resulting abdominal problems |
| 09/30/2010 | US20100247488 Paramyxoviridae Virus Preparations |
| 09/30/2010 | US20100247487 In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors |
| 09/30/2010 | US20100247454 Compositions for elastogenesis and connective tissue treatment |
| 09/30/2010 | CA2756818A1 Method of tissue repair |
| 09/30/2010 | CA2756801A1 Tissue kallikrein for the treatment of pancreatic .beta.-cell dysfunction |
| 09/30/2010 | CA2756779A1 Compositions and methods for treatment of renal disease |
| 09/30/2010 | CA2756729A1 Method for producing lactic acid bacteria having enhanced immunoregulating activities |
| 09/30/2010 | CA2756600A1 Human umbilical cord tissue cells as therapy for alzheimer's disease |
| 09/30/2010 | CA2756594A1 Tumor suppression using human placenta-derived intermediate natural killer cells and immunomodulatory compounds |
| 09/30/2010 | CA2756572A1 Promotion of neuronal integration in neural stem cell grafts |
| 09/30/2010 | CA2756197A1 Factor viii variants and methods of use |
| 09/30/2010 | CA2756152A1 9h-pyrrolo[2,3-b: 5,4-c'] dipyridine azacarboline derivatives, preparation thereof, and therapeutic use thereof |
| 09/29/2010 | EP2233150A2 Erythropoietin for use in the treatment of wounds or the transplantation of cells |
| 09/29/2010 | EP2231205A2 Colloidal collagen burn wound dressing produced from jellyfish |
| 09/29/2010 | EP2231181A1 New vaccine for the treatment of mycobacterium related disorders |
| 09/29/2010 | EP2231173A1 Nutraceutical composition and methods of use |
| 09/29/2010 | EP2231172A1 Immunomodulating compositions and uses therefor |
| 09/29/2010 | EP2231170A2 Virus-, bacteria-, and fungi-interacting layered phyllosilicates and methods of use |
| 09/29/2010 | EP2231130A1 Formulations comprising exine shells |
| 09/29/2010 | EP1907532B1 Biological materials and uses thereof |
| 09/29/2010 | EP1617852B1 Muscle derived cells (mdcs) for promoting and enhancing nerve repair and regeneration |
| 09/29/2010 | EP1608411B1 Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure. |
| 09/29/2010 | EP1476120B1 Treatment methods using anti-cd22 antibodies |
| 09/29/2010 | EP1223956B1 Supernatant from mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| 09/29/2010 | CN1970045B Externally applied Chinese medicine for treating cervical and lumbar spondylosis |
| 09/29/2010 | CN1947754B Medicine for treating infantile asthma and its preparation method |
| 09/29/2010 | CN1935254B Method for neuregulin treating cardio vascular disease, and composition |
| 09/29/2010 | CN1883634B Preparation process of stomach-caring Chinese medicine with monkey head mushroom |
| 09/29/2010 | CN1868505B 蛇胆粉胶囊 Snake Powder Capsules |
| 09/29/2010 | CN1842588B Novel lactobacillus, living body activating lactobacillus preparation and preventive or therapeutic agent against living body infection |
| 09/29/2010 | CN101848866A Water-purifying apparatus generating anions and processing method thereof |
| 09/29/2010 | CN101848746A Methods of restoration of erectile function |
| 09/29/2010 | CN101848718A Cell composition for tissue regeneration |
| 09/29/2010 | CN101848643A Use of a bifidobacterium strain for preparing a composition for preventing and/or treating allergic manifestations |
| 09/29/2010 | CN101845416A Adipose-derived stem cell for senile dementia treatment |